MCRB - Seres Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts8888
Avg. Estimate-0.49-0.53-2.06-1.69
Low Estimate-0.64-0.65-2.44-2.52
High Estimate-0.4-0.38-1.7-1.21
Year Ago EPS-0.68-0.54-2.43-2.06
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts8888
Avg. Estimate8.13M5.95M29.33M40.91M
Low Estimate3.9M3M20.6M18.7M
High Estimate11.9M9.26M35.2M96.21M
Year Ago Sales4.61MN/A28.27M29.33M
Sales Growth (year/est)76.30%N/A3.80%39.50%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.63-0.52-0.5-0.39
EPS Actual-0.68-0.54-0.52-0.59
Difference-0.05-0.02-0.02-0.2
Surprise %-7.90%-3.80%-4.00%-51.30%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.49-0.53-2.06-1.69
7 Days Ago-0.49-0.53-2.06-1.69
30 Days Ago-0.49-0.53-2.06-1.69
60 Days Ago-0.48-0.56-1.84-1.78
90 Days Ago-0.41-0.53-1.77-1.57
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days23N/A3
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMCRBIndustrySectorS&P 500
Current Qtr.27.90%N/AN/A0.02
Next Qtr.1.90%N/AN/A0.04
Current Year15.20%N/AN/A0.05
Next Year18.00%N/AN/A0.10
Next 5 Years (per annum)-134.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A